Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Hartkopf

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
Oncotarget|September 16, 2020
Sequencing for an interdisciplinary molecular tumor board in patients with advanced breast cancer: experiences from a case seriesChristina Walter, Andreas Hartkopf, Andre Koch, et al.
Archives of Gynecology and Obstetrics|July 17, 2023
Evaluating ChatGPT as an adjunct for the multidisciplinary tumor board decision-making in primary breast cancer casesStefan Lukac, Davut Dayan, Visnja Fink, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|November 2, 2013
Clinical and pathological characteristics, pathological reevaluation and recurrence patterns of cellular leiomyomas: a retrospective study in 76 patientsRalf Rothmund, Ralf-Rainer Kurth, Nadia-Maria Lukasinski, et al.
Oncology Research and Treatment|August 17, 2018
Implementation of a Systematic Literature Search Strategy in a National Breast Cancer Guideline: The Relevance of Systemic Therapy in Lymph Node Recurrent DiseaseTanja N Stüber, Stephanie Stangl, Christian Jackisch, et al.
Oncology Research and Treatment|September 25, 2023
[Therapiesteuerung in der Hämatologie und Onkologie]C Benedikt Westphalen, Bernd J Krause, Markus Schuler, et al.
Cancers|June 24, 2022
A Platform of Patient-Derived Microtumors Identifies Individual Treatment Responses and Therapeutic Vulnerabilities in Ovarian CancerNicole Anderle, André Koch, Berthold Gierke, et al.
Cancer Letters|May 12, 2025
Association of CMV status with response to neoadjuvant chemoimmunotherapy in early triple-negative breast cancerVincent Walter, André Koch, Dorothea Hillmann, et al.
Cancers|March 14, 2019
Molecular Subtype Conversion between Primary and Metastatic Breast Cancer Corresponding to the Dynamics of Apoptotic and Intact Circulating Tumor CellsStefan Stefanovic, Thomas M Deutsch, Ralph Wirtz, et al.
Diagnostics (Basel, Switzerland)|June 10, 2020
Impact of mRNA-Assessed Molecular Subtype Conversion, Intact and Apoptotic Circulating Tumor Cells on Survival of Metastatic Breast Cancer Patients: Proof of PrincipleStefan Stefanovic, Thomas M Deutsch, Ralph Wirtz, et al.
Cancers|January 11, 2025
Oral Maintenance Therapy in Early Breast Cancer-How Many Patients Are Potential Candidates?Nikolas Tauber, Lisbeth Hilmer, Dominik Dannehl, et al.
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Oncotarget|September 16, 2020
Sequencing for an interdisciplinary molecular tumor board in patients with advanced breast cancer: experiences from a case seriesChristina Walter, Andreas Hartkopf, Andre Koch, et al.
Archives of Gynecology and Obstetrics|July 17, 2023
Evaluating ChatGPT as an adjunct for the multidisciplinary tumor board decision-making in primary breast cancer casesStefan Lukac, Davut Dayan, Visnja Fink, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|November 2, 2013
Clinical and pathological characteristics, pathological reevaluation and recurrence patterns of cellular leiomyomas: a retrospective study in 76 patientsRalf Rothmund, Ralf-Rainer Kurth, Nadia-Maria Lukasinski, et al.
Oncology Research and Treatment|August 17, 2018
Implementation of a Systematic Literature Search Strategy in a National Breast Cancer Guideline: The Relevance of Systemic Therapy in Lymph Node Recurrent DiseaseTanja N Stüber, Stephanie Stangl, Christian Jackisch, et al.
Oncology Research and Treatment|September 25, 2023
[Therapiesteuerung in der Hämatologie und Onkologie]C Benedikt Westphalen, Bernd J Krause, Markus Schuler, et al.
Cancers|June 24, 2022
A Platform of Patient-Derived Microtumors Identifies Individual Treatment Responses and Therapeutic Vulnerabilities in Ovarian CancerNicole Anderle, André Koch, Berthold Gierke, et al.
Cancer Letters|May 12, 2025
Association of CMV status with response to neoadjuvant chemoimmunotherapy in early triple-negative breast cancerVincent Walter, André Koch, Dorothea Hillmann, et al.
Cancers|March 14, 2019
Molecular Subtype Conversion between Primary and Metastatic Breast Cancer Corresponding to the Dynamics of Apoptotic and Intact Circulating Tumor CellsStefan Stefanovic, Thomas M Deutsch, Ralph Wirtz, et al.
Diagnostics (Basel, Switzerland)|June 10, 2020
Impact of mRNA-Assessed Molecular Subtype Conversion, Intact and Apoptotic Circulating Tumor Cells on Survival of Metastatic Breast Cancer Patients: Proof of PrincipleStefan Stefanovic, Thomas M Deutsch, Ralph Wirtz, et al.
Cancers|January 11, 2025
Oral Maintenance Therapy in Early Breast Cancer-How Many Patients Are Potential Candidates?Nikolas Tauber, Lisbeth Hilmer, Dominik Dannehl, et al.
Pageof 9